| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/02/2002 | EP1200616A2 Enhanced delivery via serpin enzyme complex receptor ligands |
| 05/02/2002 | EP1200572A1 Antisense modulation of liver glycogen phosphorylase expression |
| 05/02/2002 | EP1200555A1 Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
| 05/02/2002 | EP1200521A1 Dispersion comprising a non-ionic emulsifier |
| 05/02/2002 | EP1200519A1 Pre-formed, self-adhesive sheet devices suitable for topical application |
| 05/02/2002 | EP1200443A1 Aromatic esters of camptothecins and methods to treat cancers |
| 05/02/2002 | EP1200321A1 Valve with a valve stem wiper |
| 05/02/2002 | EP1200320A1 Valve with a two-component seal |
| 05/02/2002 | EP1200317A1 A device for spray dispensing a composition for topical application comprising vitamin e and essential fatty acids |
| 05/02/2002 | EP1200151A1 Drug delivery device for insertion into the vagina, rectum or nasal cavity |
| 05/02/2002 | EP1200129A1 Taste masking of oral quinolone liquid preparations using ion exchange resins |
| 05/02/2002 | EP1200128A1 Preserved pharmaceutical formulations |
| 05/02/2002 | EP1200127A2 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 05/02/2002 | EP1200118A1 A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug |
| 05/02/2002 | EP1200115A2 Multi-dose erythropoietin formulations |
| 05/02/2002 | EP1200109A1 Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions |
| 05/02/2002 | EP1200100A1 Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration |
| 05/02/2002 | EP1200096A1 Tixocortol pivalate suspension, mouth-wash based thereon and packaging containing same |
| 05/02/2002 | EP1200092A2 Beta-carboline drug products |
| 05/02/2002 | EP1200091A1 Beta-carboline pharmaceutical compositions |
| 05/02/2002 | EP1200090A1 Beta-carboline pharmaceutical compositions |
| 05/02/2002 | EP1200085A1 Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents |
| 05/02/2002 | EP1200082A1 Preparations for reducing oxygen consumption during physical efforts |
| 05/02/2002 | EP1200071A2 Low-dose tablets and preparation method |
| 05/02/2002 | EP1200070A1 Ambroxol-containing lozenge |
| 05/02/2002 | EP1200069A1 A binder for pharmaceutical compositions |
| 05/02/2002 | EP1200068A2 Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
| 05/02/2002 | EP1200067A1 Delivery system for biological material |
| 05/02/2002 | EP1200066A1 Aqueous nasal formulation |
| 05/02/2002 | EP1200065A1 Intravaginal clindamycin ovule composition |
| 05/02/2002 | EP1200064A1 Delivery system for oral care compositions comprising organosiloxane reins using a removable backing strip |
| 05/02/2002 | EP1200057A1 Colloidal composition for esthetic correction |
| 05/02/2002 | EP1200042A2 Emulsifier-free finely dispersed systems of the oil-in-water type |
| 05/02/2002 | EP1200039A2 Emulsifier-free finely dispersed water-in-oil-type systems |
| 05/02/2002 | EP1199956A1 Article for applying a topical composition and method for preparing same |
| 05/02/2002 | EP1128835A4 Cyanocobalamin (vitamin b 12?) treatment in allergic disease |
| 05/02/2002 | EP1089720B1 Transdermal therapeutic system containing hormones and crystallization inhibitors |
| 05/02/2002 | EP0975216A4 A method for treating papillomavirus infections |
| 05/02/2002 | EP0941097B1 Use of mixtures of active substances for the production of hypocholesteremic agents |
| 05/02/2002 | EP0928192B1 Antimycotic gel with high active substance release |
| 05/02/2002 | EP0910375B1 A composition of enalapril and losartan |
| 05/02/2002 | EP0904031A4 Cationic polymer/lipid nucleic acid delivery vehicles |
| 05/02/2002 | EP0890359B1 Tablets containing beta-lactam antibiotic and process for producing the same |
| 05/02/2002 | EP0814784B1 USE OF NSAIDs FOR TREATMENT OF SQUAMOUS CELL CARCINOMAS OF THE ORAL CAVITY OR OROPHARYNX |
| 05/02/2002 | DE10118312A1 Solid particles for transporting hydrophobic active agents, e.g. drugs or nucleic acids, obtained from organic solvent solution of active agent and water-insoluble and amphiphilic polymers by ultrasonication and dialysis |
| 05/02/2002 | DE10053512A1 10C terpene alcohols ethoxyated with 3-10 mols of ethylene oxide are used as solubilizers for difficultly water-soluble or -dispersible compounds in pharmaceutical or cosmetic compositions or in food concentrates |
| 05/02/2002 | DE10053397A1 Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen Use of a dopaminergic agent for the treatment of dopaminergic treatable diseases |
| 05/02/2002 | DE10052322A1 Storage-stable solid chlorhexidine composition used for preparing aqueous disinfectant solutions e.g. for skin disinfection contains sugar acid and microbicidal quaternary ammonium bromide |
| 05/02/2002 | DE10038364A1 Pharmazeutische, Ramipril enthaltende Brauseformulierung Pharmaceutical, ramipril containing effervescent formulation |
| 05/02/2002 | CA2678256A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 05/02/2002 | CA2427005A1 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 05/02/2002 | CA2426674A1 Agent for preventing or treating portal hypertension |
| 05/02/2002 | CA2426402A1 Methods and instruments for treating pseudoarthrosis |
| 05/02/2002 | CA2426360A1 Enhancers for microbiological disinfection and targeted apoptosis |
| 05/02/2002 | CA2426244A1 Lipid formulations for target delivery |
| 05/02/2002 | CA2422901A1 Use of tolterodine to treat asthma |
| 05/02/2002 | CA2422900A1 New composition and method for the treatment of dysglucaemia |
| 05/02/2002 | CA2422786A1 Self-adhesive hydratable matrix for topical therapeutic use |
| 05/02/2002 | CA2421885A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 05/02/2002 | CA2420590A1 Active agent delivery systems and methods for protecting and administering active agents |
| 05/02/2002 | CA2419373A1 Use of hydroxyeicosatetraenoic acid derivatives in intraocular surgery |
| 05/01/2002 | CN2488504Y Self-heating type adhesive plaster |
| 05/01/2002 | CN1347450A Composition for preservation of infections recombinant adenoviruses |
| 05/01/2002 | CN1347413A Crystalline form of omeprazole |
| 05/01/2002 | CN1347324A Composition for treatment of psoriasis |
| 05/01/2002 | CN1347315A Method for producing water-insoluble amorphous or partially amorphous controlled release matrix |
| 05/01/2002 | CN1347314A Controlled release formulation for treating COPD |
| 05/01/2002 | CN1347313A High potency dihydroergotamine compositions |
| 05/01/2002 | CN1346664A Exterior-applied Chinese-medicinal pill for treating diarrhea |
| 05/01/2002 | CN1346663A Exterior-applied ointment for treating skin injury and its preparing process |
| 05/01/2002 | CN1346655A Liquid medicine for treating traumatic injury |
| 05/01/2002 | CN1346641A Freezed dried centipede |
| 05/01/2002 | CN1346640A Freeze dried leech capsule |
| 05/01/2002 | CN1346634A Process for preparing miconazole nitrate ointment |
| 05/01/2002 | CN1346633A 利巴韦林脂质体制剂 Ribavirin liposomal formulation |
| 05/01/2002 | CN1083714C Microcapsule contg. chemotherapeutic medicine and capsule-forming method |
| 05/01/2002 | CN1083713C Bilayer preparations |
| 04/30/2002 | US6380405 Taxane prodrugs |
| 04/30/2002 | US6380403 Illudin analogs useful as antitumor agents |
| 04/30/2002 | US6380359 Liposomes comprising peptide antigens derived from X protein of hepatitis B virus |
| 04/30/2002 | US6380255 Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds |
| 04/30/2002 | US6380236 Method of treating onychomycosis |
| 04/30/2002 | US6380234 Homogenity mixing, granulation, enteric coating |
| 04/30/2002 | US6380198 Lowering the intraocular pressure |
| 04/30/2002 | US6380163 Containing osmotic agent with an additional osmotic agent such as dextrose |
| 04/30/2002 | US6379715 Method for treatment of psoriasis |
| 04/30/2002 | US6379707 Solid solution of amorphous pharmaceutically active agent, pharmaceutically acceptable hydrophobic vehicle, stabilizer, disintegrant; shelf life |
| 04/30/2002 | US6379706 Rapidly disintegrating coated pellets with delayed release |
| 04/30/2002 | US6379705 Pellets; controlling concentration |
| 04/30/2002 | US6379704 Method for preparing microparticles having a selected polymer molecular weight |
| 04/30/2002 | US6379703 Preparation of microparticles having a selected release profile |
| 04/30/2002 | US6379702 Flexibility; contour conforming; applying to skins |
| 04/30/2002 | US6379701 Controlled release of metal cation-stabilized interferon |
| 04/30/2002 | US6379700 An oil-in-water fluid emulsion prepared by phase inversion and comprising an emulsifier is sprayed at room temperature onto a powder, e.g. drugs, to coat; compression to obtain tablets |
| 04/30/2002 | US6379699 Liposome having attached target-binding moiety and artherosclerotic plaque interacting moiety |
| 04/30/2002 | US6379698 Fusogenic lipids and vesicles |
| 04/30/2002 | US6379697 Liposomes |
| 04/30/2002 | US6379696 Adjust absorption |
| 04/30/2002 | US6379695 Betamethasone- and hyaluronic acid-treated thin adhesive plaster for the treatment of psoriasis dermatitis and dermatosis |
| 04/30/2002 | US6379692 Water insoluble drug ; adjustment of ph with acid |